- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/54 - Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
Patent holdings for IPC class C07D 239/54
Total number of patents in this class: 496
10-year publication summary
|
35
|
29
|
28
|
30
|
33
|
42
|
23
|
25
|
26
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 20940 |
28 |
| Corcept Therapeutics, Inc. | 343 |
20 |
| Abbvie Inc. | 1800 |
18 |
| Bayer AG | 3325 |
12 |
| Takeda Pharmaceutical Company Limited | 2708 |
11 |
| Carnegie Mellon University | 1537 |
11 |
| F. Hoffmann-La Roche AG | 7947 |
9 |
| EA Pharma Co., Ltd. | 88 |
9 |
| Merck Sharp & Dohme LLC | 3751 |
9 |
| ADAMA Agan Ltd. | 375 |
8 |
| Bristol-myers Squibb Company | 4880 |
7 |
| Glaxosmithkline LLC | 537 |
7 |
| Taisho Pharmaceutical Co., Ltd. | 875 |
7 |
| Jiangsu Flag Chemical Industry Co., Ltd. | 32 |
7 |
| Bayer Cropscience AG | 2040 |
6 |
| FMC Corporation | 845 |
6 |
| Korea Research Institute of Chemical Technology | 1393 |
6 |
| Shionogi & Co., Ltd. | 852 |
6 |
| E. I. du Pont de Nemours and Company | 4050 |
5 |
| Abbott Laboratories | 2402 |
5 |
| Other owners | 299 |